Congress trades
AptarGroup, Inc. (ATR)
About AptarGroup, Inc.
from the company's filings and listing- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Chief executive
- Gael Touya
- Employees
- 14,000
- Listed since
- Apr 23, 1993
- Market value
- $7.8B
- Price to earnings
- 21.8
- Earnings per share
- $5.68
- Dividend yield
- 1.57%
Earnings
6 reported quarters · next on Oct 29, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Jul 30, 2026 | $1.42 | $1.35 | $1.0B | $1.0B | EPS beatRevenue beat |
| Q1 FY2026reported Apr 30, 2026 | $1.19 | $1.15 | $982.9M | $956.0M | EPS beatRevenue beat |
| Q4 FY2025reported Feb 5, 2026 | $1.25 | $1.24 | $962.7M | $878.6M | EPS in lineRevenue beat |
| Q3 FY2025reported Oct 30, 2025 | $1.62 | $1.57 | $961.1M | $880.2M | EPS beatRevenue beat |
| Q2 FY2025reported Jul 31, 2025 | $1.66 | $1.58 | $966.0M | $959.0M | EPS beatRevenue in line |
| Q1 FY2025reported May 1, 2025 | $1.20 | $1.16 | $887.3M | $898.6M | EPS beatRevenue in line |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2025 · proxy filed Mar 27, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Stephan B. TandaPresident and Chief Executive Officer | $1.2M | $6.1M | $3.0M | $10.2M |
| Gael TouyaPresident, Aptar Pharma | $653K | $937K | $2.0M | $3.6M |
| Vanessa KanuExecutive Vice President and Chief Financial Officer | $720K | $2.0M | $869K | $3.6M |
| Hedi TliliPresident, Aptar Closures | $620K | $748K | $1.3M | $2.6M |
| Xiangwei GongExecutive Vice President, Strategic Group Development | $569K | $738K | $1.1M | $2.4M |
| Marc PrieurPresident, Aptar Beauty | $722K | $851K | $668K | $2.2M |
The summary compensation table from the 2025 proxy statement, current executives only. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Blackrock, Inc. | $768.5M | 6,137,894 | +0.9% | 9.61% |
| State Farm Mutual Automobile Insurance Co | $594.0M | 4,744,564 | 0.0% | 7.43% |
| Vanguard Portfolio Management LLC | $455.6M | 3,638,724 | -3.4% | 5.70% |
| Morgan Stanley | $441.2M | 3,523,908 | +4.4% | 5.52% |
| Vanguard Capital Management LLC | $362.3M | 2,893,751 | +0.3% | 4.53% |
| State Street Corp | $358.5M | 2,863,390 | +2.8% | 4.49% |
| Victory Capital Management Inc | $319.8M | 2,554,561 | +5.6% | 4.00% |
| Geode Capital Management, LLC | $218.9M | 1,747,815 | +3.2% | 2.74% |
| Dimensional Fund Advisors LP | $218.0M | 1,741,294 | +15.7% | 2.73% |
| Neuberger Berman Group LLC | $193.9M | 1,548,824 | +31.9% | 2.43% |
| Fiduciary Management Inc | $178.3M | 1,423,771 | +13.7% | 2.23% |
| River Road Asset Management, LLC | $169.1M | 1,350,700 | +14.8% | 2.12% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Congress trades in ATR
16 disclosures of 16 on record · median 38d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Michael T. McCaul | Stock | Purchase | $15,001 - $50,000 | +2.8%S&P +15.2% · vs S&P 500 -12.4% | Nov 19, 2025 | Dec 9, 2025 | 20d |
| Michael T. McCaul | Stock | Purchase | $15,001 - $50,000 | -8.6%S&P +14.2% · vs S&P 500 -22.8% | Sep 22, 2025 | Oct 10, 2025 | 18d |
| Michael T. McCaul | Stock | Purchase | $1,001 - $15,000 | -11.5%S&P +16.1% · vs S&P 500 -27.6% | Sep 11, 2025 | Oct 10, 2025 | 29d |
| Michael T. McCaul | Stock | Purchase | $15,001 - $50,000 | -13.7%S&P +20.8% · vs S&P 500 -34.4% | Aug 7, 2025 | Sep 11, 2025 | 35d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | -13.8%S&P +20.2% · vs S&P 500 -33.9% | Aug 21, 2025 | Sep 11, 2025 | 21d |
| Lisa C. McClainSpouseFiled late | Stock | Purchase | $1,001 - $15,000 | -21.2%S&P +25.5% · vs S&P 500 -46.6% | Jun 24, 2025 | Aug 13, 2025 | 50d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | -19.2%S&P +36.2% · vs S&P 500 -55.4% | Aug 26, 2024 | Sep 16, 2024 | 21d |
| Michael T. McCaul | Stock | Purchase | $1,001 - $15,000 | -1.3%S&P +80.7% · vs S&P 500 -82.1% | Nov 1, 2023 | Dec 9, 2023 | 38d |
| Michael T. McCaul | Stock | Purchase | $15,001 - $50,000 | -1.3%S&P +80.7% · vs S&P 500 -82.1% | Nov 1, 2023 | Dec 9, 2023 | 38d |
| Michael T. McCaul | Stock | Purchase | $50,001 - $100,000 | +13.1%S&P +84.9% · vs S&P 500 -71.8% | Aug 8, 2022 | Sep 19, 2022 | 42d |
| Susie LeeJoint | Stock | Sale | $1,001 - $15,000 | +2.4%S&P +153.8% · vs S&P 500 -151.4% | Sep 13, 2019 | Oct 21, 2019 | 38d |
| Susie LeeJoint | Stock | Sale | $1,001 - $15,000 | +2.2%S&P +154.5% · vs S&P 500 -152.2% | Sep 11, 2019 | Oct 21, 2019 | 40d |
| Susie LeeJointFiled late | Stock | Sale | $1,001 - $15,000 | -1.7%S&P +154.2% · vs S&P 500 -156.0% | Jul 12, 2019 | Aug 29, 2019 | 48d |
| Lizzie FletcherSpouseFiled late | Stock | Sale | $1,001 - $15,000 | +20.5%S&P +172.9% · vs S&P 500 -152.4% | Feb 26, 2019 | Apr 23, 2019 | 56d |
| Bradley Scott SchneiderSpouse | Stock | Sale | $250,001 - $500,000 | +19.5%S&P +173.6% · vs S&P 500 -154.1% | Mar 5, 2019 | Apr 6, 2019 | 32d |
| Bradley Scott SchneiderSpouse | Stock | Purchase | $250,001 - $500,000 | +20.0%S&P +179.6% · vs S&P 500 -159.6% | Feb 5, 2019 | Feb 17, 2019 | 12d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Questions
Which members of Congress have traded ATR?
Michael T. McCaul, Lisa C. McClain, Susie Lee, Lizzie Fletcher, Bradley Scott Schneider disclosed ATR transactions in the filings shown here.
How quickly are ATR trades disclosed?
Congressional disclosures took a median of 38 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.